ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.498,38
0,32%
S&P 500
5.187,67
0,00%
Dow Jones
39.056,39
0,44%
Euro vs US Dollar
1,07432
-0,03%
Bitcoin
61.437,54
0,41%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Titan Pharmaceuticals Inc (TTNP)

  7. Titan Pharmaceuticals Inc (TTNP) News

TTNP

Titan Pharmaceuticals (TTNP)

Titan Pharmaceuticals Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:TTNP
DatumZeitQuelleÜberschriftSymbolFirma
25/01/202422h33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TTNPTitan Pharmaceuticals Inc
25/01/202422h29GlobeNewswire Inc.Titan Pharmaceuticals Fully Compliant With NASDAQ Listing CriteriaNASDAQ:TTNPTitan Pharmaceuticals Inc
18/01/202422h59Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TTNPTitan Pharmaceuticals Inc
08/01/202423h13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TTNPTitan Pharmaceuticals Inc
28/12/202322h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TTNPTitan Pharmaceuticals Inc
28/12/202322h15GlobeNewswire Inc.Titan Pharmaceuticals Announces Reverse Stock Split and RatioNASDAQ:TTNPTitan Pharmaceuticals Inc
28/11/202322h47Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:TTNPTitan Pharmaceuticals Inc
17/11/202322h03Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:TTNPTitan Pharmaceuticals Inc
15/11/202322h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TTNPTitan Pharmaceuticals Inc
26/10/202322h33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTNPTitan Pharmaceuticals Inc
26/10/202322h31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTNPTitan Pharmaceuticals Inc
26/10/202322h29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTNPTitan Pharmaceuticals Inc
26/10/202322h25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTNPTitan Pharmaceuticals Inc
26/10/202322h23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTNPTitan Pharmaceuticals Inc
24/10/202323h26Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TTNPTitan Pharmaceuticals Inc
23/10/202321h07Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TTNPTitan Pharmaceuticals Inc
16/10/202323h08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TTNPTitan Pharmaceuticals Inc
16/10/202322h37GlobeNewswire Inc.Titan Pharmaceuticals Announces Appointment of Dato' Seow Gim Shen and Brynner Chaim to the Company's Board of DirectorsNASDAQ:TTNPTitan Pharmaceuticals Inc
04/10/202323h30Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:TTNPTitan Pharmaceuticals Inc
04/10/202322h40Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TTNPTitan Pharmaceuticals Inc
19/09/202322h41Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:TTNPTitan Pharmaceuticals Inc
18/09/202322h45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TTNPTitan Pharmaceuticals Inc
18/09/202313h30GlobeNewswire Inc.Titan Pharmaceuticals Announces $9.5 Million Private Placement of Convertible Preferred StockNASDAQ:TTNPTitan Pharmaceuticals Inc
08/09/202323h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TTNPTitan Pharmaceuticals Inc
30/08/202322h28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TTNPTitan Pharmaceuticals Inc
14/08/202323h08Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TTNPTitan Pharmaceuticals Inc
01/08/202302h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTNPTitan Pharmaceuticals Inc
01/08/202301h45Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:TTNPTitan Pharmaceuticals Inc
01/08/202301h44Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:TTNPTitan Pharmaceuticals Inc
01/08/202301h42Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:TTNPTitan Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:TTNP

Kürzlich von Ihnen besucht

TG
NOV
Novo Nordisk
TG
DTE
Deutsche Telekom
CCOM
SILVER
SILVER
NASDAQ
NVDA
NVIDIA
NYSE
JPM
JP Morgan Chase
NASDAQ
AMZN
Amazon.com
DBI
MDAX
MDAX
TG
BAS
BASF
CCOM
US30
US 30
TG
CBK
Commerzbank
TG
BAYN
Bayer
AMEX
XLF
Financial Select Sector
TG
ALV
Allianz
USOTC
DTEGY
Deutsche Telekom (QX)
NASDAQ
AAPL
Apple
TG
D7G
Nel ASA
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten